Allergy and Immunology | News, Education and Events

Recent News on Allergies and Immunologic Disorders

The following outside resources contain helpful information for families and healthcare professionals facing allergy- and immunology-related disorders. Cincinnati Children’s also provides further information on advocacy.

Info on COVID-19

Get updated information about the novel coronavirus (COVID-19) and how it affects patients with allergy / asthma conditions. Read more

In the News


Eosinophil responses during COVID-19 infections and coronavirus vaccinations 


FDA-Approved Drug Reverses Inflammation in Animal Model of Eosinophilic Esophagitis


Progress Update for Eosinophilic Disorder Research


EGIDExpress Tool Helps Accelerate EoE Research


EOS Network - Your Questions Answered by EOS Network Professionals


Unlocking the Secrets of Eosinophilic Esophagitis: A New Children’s Book


A preliminary report (not peer-reviewed) - Alpha I Antitrypsin is an Inhibitor of the SARS-CoV2-Priming Protease TMPRSS2


The ABCs of EGIDs - online web-based education module


SECURE-EoE/EGID - Coronavirus and EoE/EGID Reporting Database


Research survey for rare disease patients and their families about impacts of COVID-19


Congratulations to Melissa Mingler, MS, MBA, the Business Manager in the Division of Allergy and Immunology, on her election as Treasurer for the Midwest Section of the Society of Research Administrators International (SRAI). Mel currently serves as the Treasurer of the Ohio Chapter of SRAI and is now taking that experience to a higher level to serve the Midwest Section.


Congratulations to Rishi Mehta of the Rothenberg Lab for being selected as a 2020 Barry Goldwater Scholar by the Barry Goldwater Scholarship and Excellence in Education Foundation.


Kimberly A. Risma, MD, PhD was elected as Vice Chair of the Program Directors Assembly Executive Committee 2020-2022 and will serve as chair 2022-2024 for the American Academy of Allergy, Asthma and Immunology (AAAAI).

February 24

RDCRN Spotlight: Patients Power Research in Eosinophilic Gastrointestinal Disorders

February 21

Cincinnati Children's Patient Story: Nebraska Family Finds Answers & Food Options for Kids with EoE

February 19

EOS Network Website is Live!

February 17

Cincinnati Children's Patient Story: Three Matching Shirts, Three Matching Diagnoses

February 11

RDCRN Spotlight: NIH's Rare Diseases Clinical Research Network Launches New Logo

February 3

Michelle B. Lierl, MD celebrates with colleagues. 

Congratulations to our colleague Michelle B. Lierl, MD, who was recognized by the Patient & Family Experience (PFE) and Ambulatory teams this quarter for outstanding PFE in the Ambulatory setting. Dr. Lierl has been identified for this recognition based on a review of scores and positive comments that highlights the exceptional feedback she routinely receives from the patients and families she serves. During her February 3rd clinic, she was surprised with the news of this award!

February 3

Amal H. Assa’ad, MD speaks in this news video by WLWT5 about the FDA approving a new drug to help children with peanut allergy.

January 6

Research Horizons: New Tests May Help Diagnose Rare Subset of Eosinophilic Disorders


Our local colleague Michael G. Sherenian, MD, MS was selected as one of the 2020 AAAAI Foundation Faculty Development Award recipients, which is an honor and recognition of his accomplishments and plans.


Kimberly A. Risma, MD, PhD is making great strides in drug allergy treatment and awareness. Please support awareness of penicillin allergy and its over diagnosis by watching this video and learning more at the recently launched webpages of the Drug Allergy Program at Cincinnati Children's!


Marc E. Rothenberg, MD, PhD was pleased to assist NORD this year in preparation of the Eosinophilic Esophagitis report for the Rare Disease Database!


How to Talk to Party Hosts About Kids' Nut Allergies


Lawmakers Propose Council to Help People With Rare Diseases


Nucala (mepolizumab) is the first treatment to show a significant reduction in flares for patients with Hypereosinophilic Syndrome (HES) 


5th CURED EGID Research Conference and Patient Education Program and "The CURED" Video


Penicillin Allergy Testing Service set to launch in mid-November


AP-1 activity induced by co-stimulation is rehired for chromatin opening during T cell activation

Marc E. Rothenberg, MD, PhD, shares, "I am pleased to share this research from the Barski Lab. This is an important contribution to the field, defining the epigenetic and transcriptional processes involved in T cell memory. This has direct implications in understanding the immunologic basis of a variety of diseases including allergy." 


5th CURED Research Conference and Patient Education Program Begins Nov. 7


Efficacy of Dupilumab in Phase 2 Randomized Trial of Adults with Active Eosinophilic Esophagitis

Marc E. Rothenberg, MD, PhD, shares, "These positive data are good news for the patients, as this is a very promising therapy for eosinophilic esophagitis (EoE). This is also good news for the research field, as these clinical results are based on over a decade of research by the Rothenberg Lab, providing the scientific basis of blocking this pathway in EoE and related eosinophilic gastrointestinal disorders (EGIDs)." 


Travel Award by Ohio Physiological Society

Rishi Mehta, a student in the Rothenberg Lab, was awarded the AD Instruments Travel Award of the Ohio Physiological Society, which will provide support for him to attend the Experimental Biology 2020 conference. He presented his research in the Rothenberg Lab under the title of "Loss of peptidyl-arginine deiminase 1-mediated citrullination drives esophageal epithelial barrier impairment in allergic inflammation".

OPS 2019 Award


Phase 2 Randomized, Double-Blind Placebo0Controlled Study in Patients with Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis

Marc E. Rothenberg, MD, PhD, shares, "This is exciting news for the eosinophil gastrointestinal community. This early study met the key endpoints and looks promising for the future treatment of eosinophilic gastrointestinal disease. Here at Cincinnati Children's, we are pleased to have contributed to the preclinical research, design and implementation of this drug and study."


Dr. Rothenberg received the Paul Ehrlich Lectureship Award

Dr. Rothenberg, the Principal Investigator for the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR), has been awarded the highest honor bestowed by the International Eosinophil Society for his major contributions to the advancement of our understanding of the eosinophil.


Can an Antibody Against IL-13 Be Used to Treat Eosinophilic Esophagitis?


FOX Cincinnati FARE Interview

Sandy Durrani, MD, discusses the increase of allergies on local Cincinnati FOX News in an interview arranged the by Food Allergy Research and Education (FARE).


Knopp Biosciences Expands Research Collaboration with Cincinnati Children's to Characterize Effect of Dexpramipexole in Inflammatory Diseases

Through a previous collaboration with Knopp, Patricia Fulkerson, MD, PhD and her team employed an induced pluripotent stem cell (iPSC) culture system to study the ability of dexpramipexole to inhibit the maturation of eosinophil progenitor cells. Looking forward, Dr. Fulkerson and her team will investigate molecular pathways in eosinophil development and attempt to further elucidate the effect of dexpramipexole on those pathways.


Allergy and Immunology Division: Select Research Advances of 2018 Video

Through our sustained commitment to research and clinical excellence for allergic and immunologic conditions, we will continue to change the outcome together. This slideshow highlights notable scientific advances made by The Division of Allergy and Immunology at Cincinnati Children’s in 2018. Our research has advanced the understanding, diagnosis, prevention, and treatment of many rare and common allergic and immunologic diseases.


Zuckerman Scholar

Netali Morgenstern-Ben Baruch is a 2018/2019 Zuckerman Israeli Postdoctoral Scholar of the Zuckerman Scholars Program and is investigating an inhibitory receptor, ILT-2, to learn about its role in the type 2 inflammatory disease Eosinophilic esophagitis (EoE).


Marc Rothenberg, MD, PhD Recognized as a Highly Cited Researcher for 2018


New Drug Could Be Game-changer For Kids With Severe Peanut Allergies


Landmark PALISADE Trial of AR101 Published in New England Journal of Medicine - read the open-access journal article


Anti-IL-13 Phase 2 Trial for Eosinophilic Esophagitis


Proyecto EoE y Ausencia de Proteina SPINK7:Entrevista al Investigador Principal - see the October issue (pages 8-9) of the AEDESEO newsletter for an interview with Marc Rothenberg, MD, PhD


Scientists Discover Why So Many Children Born With a Defective Esophagus Develop Severe Food Allergies


DBV Technologies Announces Submission of Biologics License Application for Viaskin Peanut to the U.S. Food and Drug Administration


A revolutionary treatment for allergies to peanuts and other foods is going mainstream--but do the benefits outweigh the risks?


Thomas J. Fischer Endowed Education Fund


Durrani Spem Facit

Our clinical team members are dedicated to excellence in patient care. For Sandy Durrani, MD, this was recently recognized by a grateful patient family naming a star “Durrani Spem Facit”, which loosely translates from Latin to mean ‘hope maker’. We are so proud of Sandy and all of our stellar team members for changing the outcome together.


Eosinophilic Esophagitis Video: What is EoE?


Study Finds Absence of Key Protein, SPINK7, May Drive EoE: Replacement Therapy Reversed Effects in Tissue Experiments


Discovery Could Lead to Personalized Medical Therapies for Emerging New Food Allergy Disorder


Creating a multi-center rare disease consortium - the Consortium of Eosinophilic Gastrointestinal Disease Researchers
This is a fantastic summary of the formation of CEGIR, the Consortium of Eosinophilic Gastrointestinal Disease Researchers, the first large-scale collaboration between key stakeholders in the field of eosinophilic gastrointestinal disorders, including researchers, patients and the key funding agency, the NIH. CEGIR is dedicated to improving the lives of individuals with eosinophilic gastrointestinal disorders through innovative research, clinical expertise and education via collaborations between scientists, health care providers, patients, and professional organizations.


Tips for Hosting a Food-Allergy-Friendly Holiday Party


Cincinnati Children's Research Paves Way For Newly Approved Asthma Drug


A Family Journey
The CURED Conference brought together patient families, physicians, and researchers from across the globe to learn from each other. One of the most moving and memorable presentations was a patient perspective from Kara Root, whose story inspires us here at Cincinnati Children’s as well those across the eosinophilic gastrointestinal disorder (EGID) community. You can read more about Kara and her family’s journey on her blog.


Celebrating 140 Collective Years of Service of Allergy and Immunology at Cincinnati Children's
The Division of Allergy and Immunology is celebrating a unique year as six division faculty observe their 10-, 20-, 30-, and 40-year Cincinnati Children's service anniversaries! Their sustained contributions at multiple levels and their influence on past and future generations put the division in a strong position. Here, they offer insight into the changes they have been part of and where the division is going.


Environmental Factors Could Adjust Risk of Eosinophilic Esophagitis in People with Particular Gene Variants


Handy Checklist: Going to College with an Eosinophilic Gastrointestinal Disorder


Pushing for Progress in a Rare Eosinophilic Condition: Eosinophilic Gastritis


What's the right time to use an EpiPen?
Amal H. Assa'ad, MD comments about administering epinephrine auto-injectors for anaphylaxis in this news video.


Family Fights For Formula Coverage Despite it Being Illinois Law
In this NCB Chicago news segment, Marc E. Rothenberg, MD, PhD and professional and family colleagues comment about insurance coverage for medical formulas.

MAY 22

FARE Patient Registry
The FARE Patient Registry launched on May 22, 2017 and is a patient-powered research registry, created with collaboration by FARE’s Medical Advisory Board, members of the Outcomes Research Advisory Board and AltaVoice, a leading registry platform and expert in the field of online protection and privacy.

MAY 17

FDA-approved drug helps treat rare immunologic disease, study finds
The NIH reports on a phase 3 clinical trail that they co-funded and that tested mepolizumab (humanized antibody against IL-5) as an alternative treatment for an eosinophilic syndrome, eosinophilic granulomatosis with polyangiitis (EGPA; previously known as Churg-Strauss syndrome).


2017 FARE Research Retreat: Q&A with Dr. Simon Hogan
Simon P. Hogan, PhD, received a FARE Investigator in Food Allergy Award in 2015. With this support, the Hogan Lab is investigating how proteins released at the start of an allergic response can cause blood vessels to leak during life-threatening anaphylaxis. Understanding the chain of chemical events that leads to anaphylactic shock is a key step in devising strategies to prevent severe food allergy symptoms. Hogan presented at the FARE 2017 Research Retreat and explains his work in this Q&A on the FARE blog.


Poster of Distinction, Nutrition Research Day
Mark Rochman, PhD, and Carina Venter, PhD, RN, and their students, Rachel Ernst and Tarah Wagner won the Poster of Distinction at the Nutrition Research Day Poster Session at Cincinnati Children's for their work on peanut protein levels.Ernst and Wagner went on to take first place in the Agriculture / Food Science category at their high school's capstone competition on April 28.

Poster of Distinction at Nutrition Research Day 2017.


K08 Award
Andrew W. Lindsley, MD, PhD was awarded a K08 from the National Institute of Allergy and Infectious Diseases (NIAID). This NIH clinical scientist career development award will support the Lindsley Lab in investigating how the sphingolipid ORMDL3 regulates dendritic cells in asthma.


NIH R01 and DHC Awards
Patricia C. Fulkerson, MD, PhD was awarded an R01 from National Institute of Allergy and Infectious Diseases (NIAID). This R01 will support the Fulkerson Lab in investigating the role of the transcription factor Aiolos in eosinophilic asthma. Learn more about her research in the Fulkerson Lab.


2017 AAAAI Annual Meeting Awards
For the 2017 American Academy of Asthma, Allergy & Immunology (AAAAI) Annual Meeting, our Cincinnati Children’s/University of Cincinnati College of Medicine colleagues presented over 50 presentations, which is an impressive number. This underscores the collective impact that Cincinnati Children’s/University of Cincinnati College of Medicine is having in our field. Dr. Justin Wheeler was the recipient for the award for the 2017 AAAAI/APFED Best Oral Abstract on eosinophilic gastrointestinal diseases by a fellow-in-training. Amnah Yamani, a predoctoral student in the Hogan Lab, was selected to be in the featured poster session. Amal H. Assa’ad, MD, was selected to give the first Leonard Bernstein Lectureship. This lectureship was established in memory of our legendary Dr. Leonard Bernstein, who was a pioneer in the allergy field, founder of the allergy discipline in Cincinnati and a wonderful mentor and contributor to our program. The lectureship was sponsored by donations from the Bernstein Family and Dr. Bernstein’s past trainees and colleagues.


FADDA Interest Section
Amal H. Assa’ad, MD, was elected by her peers to serve as the Secretary of the AAAAI’s Food allergy, anaphylaxis, dermatology and drug Allergy (FADDA) Interest Section from March 5, 2017 until March 2019. After the 2019 AAAAI Annual Meeting and until the 2021 Annual Meeting, she will serve in the role as the Vice Chair of the interest section, and then from 2021 until 2023, she will serve in the role of Chair of FADDA.


Clinical Care Award
Michelle B. Lierl, MD, was selected by The Faculty Awards Committee at Cincinnati Children's for the Clinical Care Award. This is a well-deserved honor for Dr. Lierl, who is now in her 30th anniversary year at Cincinnati Children's. In addition to her great clinical service, Dr. Lierl researches fungal allergens in the Lierl Lab and has created a fungal spore photo website.


2016 Division Research Advances Video
We invite you to watch a short video detailing a few of the Division of Allergy and Immunology’s Research Advances of 2016. Through our sustained commitment to research and clinical excellence for allergic and immunologic conditions, we will continue to change the outcome together.


CURED Foundation donates for Eosinophilic Disorder Treatment and Research
The Campaign Urging Research for Eosinophilic Disease (CURED), a not-for-profit foundation dedicated to those suffering from eosinophilic disorders, has donated $200,000 to the Cincinnati Center for Eosinophilic Disorders (CCED), based at Cincinnati Children’s Hospital Medical Center. The CURED Foundation works extensively in supporting families and raising funds for research. One-hundred percent of funds raised by the CURED Foundation go to research for eosinophilic disorders. To date, CURED has contributed over 4 million dollars to research.


2017 NIAID Addendum Guidelines for Preventing Peanut Allergy
In 2015, findings from a landmark NIAID-funded clinical trial called the Learning Early About Peanut (LEAP) study showed that introducing peanut-containing foods to infants at high risk for developing peanut allergy was safe and led to an 81% relative reduction in the subsequent development of peanut allergy. Due to the strength of these results, NIAID established a coordinating committee that convened an expert panel to update the 2010 Guidelines to specifically address the prevention of peanut allergy. Amal H. Assa'ad, MD, and Carina Venter, PhD, RD, contributed to the Addendum Guidelines for the Prevention of Peanut Allergy in the United States that were published in the January 2017 issue of Annals of Allergy and Immunology, along with a guest editorial by Amal H. Assa'ad, MD.


2017 AAAAI Distinguished Service Award
Well-deserved congratulations go to Kimberly A. Risma, MD, PhD, for being selected for the 2017 Distinguished Service Award of the American Academy of Asthma, Allergy & Immunology (AAAAI) for her leadership with the Chrysalis Project. The Chrysalis Project is a program for medical students and internal medicine and/or pediatric residents that provides them the opportunity to explore a career in allergy/immunology. It is housed within the AAAAI Annual Meeting and includes pairing the Chrysalis mentee with a fellow-in-training mentor, didactic lectures with allergy/immunology faculty, career option presentations, and free conference registration and access to the leading knowledge in the hundreds of AAAAI meeting sessions, workshops, symposia, seminars, and oral abstracts. Dr. Risma has helped to propel this program to become a jewel of our society and is thus greatly impacting our field and its future. Through her efforts, she has established a ‘pipeline’ of strong physicians in our field. In 2010, Dr. Risma was nominated by the Board of AAAAI to assume the co-Chair position of the Chrysalis Program Project after a pause in the program’s funding. She has subsequently worked tirelessly on the Chrysalis Project with current AAAAI president, Dr. Tom Fleisher between 2010-15 and former AAAAI president, Dr. Wesley Burks in 2015-17. Under her leadership, the program has expanded from 20 to 50 attendees per year. The Chrysalis Project has been extraordinarily well received as is evident from the growing number of highly qualified applicants and attendees, the positive reviews, and the growing number of fellowship applicants who credit the Chrysalis Project.


Cincinnati Children’s was recently issued US Patent 9517238 B2 for the work of the inventors Marc E. Rothenberg and Mark Rochman. The invention provides methods of treating allergic inflammatory conditions using an anti-neurotrophin tyrosine kinase receptor 1 (NTRK1)-based therapeutic agent and related compositions and methods. The underlying research for this patent was conducted in the Rothenberg Lab.


Hosting a Food-Allergy-Friendly Holiday Party


FARE Joins with National Academies of Sciences, Engineering and Medicine in Call for Sweeping Changes to Improve Health, Quality of Life of Individuals With Food Allergies
We would like to mention that this vital work was made possible by so many contributors, including our colleague Carina Venter, PhD, RD, who served as a reviewer and contributor to this 500-page report on food allergy.


Trustee Grant Award
Ting Wen, PhD was awarded a Trustee Grant Award by Cincinnati Children’s to support his research.


Allergy Guideline Updating Efforts
We are proud of all the dedicated efforts made to move the guidelines for allergen introduction forward. Our colleague Amal H. Assa’ad, MD, comments in this NPR update, and our colleague Carina Venter, PhD, RD, is involved as a member of the scientific panel who are updating the guidelines that will be published in January on the National Institute of Allergy and Infectious Diseases (NIAID) website. Listen to or read the NPR segment (by Patti Neighmond). Read the Reuter's article (by Rob Goodier). Read Dr. Venter's JACI editorial about the LEAP study findings about early allergen consumption.

September 23

5 Tips for Packing a Well-Rounded Nut-free Lunch


LEAP Study Editorial
The Journal of Allergy and Clinical Immunology has included the LEAP (Learning Early About Peanut) nutrition study for its readership. Our colleague Carina Venter, PhD, RD, co-authored an editorial about the study findings about early allergen consumption.


CURED Foundation Donates for Eosinophilic Disorder Treatment and Research
The Campaign Urging Research for Eosinophilic Disease (CURED), a not-for-profit foundation dedicated to those suffering from eosinophilic disorders, has donated $100,000 to the Cincinnati Center for Eosinophilic Disorders (CCED), based at Cincinnati Children’s Hospital Medical Center. The CURED Foundation works extensively in supporting families and raising funds for research. One-hundred percent of funds raised by the CURED Foundation go to research for eosinophilic disorders. To date, CURED has contributed over 4 million dollars to research.


UC Summer Research Prepares Students for STEMM Careers
Two hundred college and high school students from the across the country participated in the 2016 Summer Undergraduate Research Fellowship (SURF) Capstone Poster Sessions sponsored by several programs at the UC College of Medicine and Cincinnati Children’s Hospital Medical Center as part of the SURF initiative, designed to provide rich research internship experiences for college students and high school seniors. All student winners were recognized during an awards ceremony. Marc Rothenberg, MD, PhD, Director of both the Division of Allergy and Immunology and the Cincinnati Center for Eosinophilic Disorders at Cincinnati Children’s, gave the ceremony’s keynote speech. At its conclusion, he eulogized Olivia Erhardt, a 2015 SURF participant and Columbia University student who performed summer research in his laboratory at Cincinnati Children’s. Erhardt tragically lost her life in a bus accident during a medical mission trip to Honduras in January 2016.

Infants and Solid Food, an Introductory Course. Carina Venter, PhD, RD, a research associate and dietician at Cincinnati Children's, discusses the transition from formula to solid food in infancy while navigating potential food allergies.

AAAAI Foundation & Dr. Donald Y.M. Leung/JACI Editors Faculty Development Award
Andrew W. Lindsley, MD, PhD, was interviewed about his recent award, the AAAAI Foundation and Dr. Donald Y.M. Leung/JACI Editors Faculty Development Award for his project investigating how ORMDL3 enhances macrophage function in asthma pathogenesis.

July 22

Darrel E. Goll Award for Scholarly Publication
Our collaborator, Leah C. Kottyan, PhD, received the Darrel E. Goll Award at the FASEB Biology of Calpains in Health and Disease Conference. This award recognizes the most outstanding publication in the field of calpains in the past three years, and we are proud for members of the Rothenberg Lab to have contributed to this outstanding work over the years. Their recent calpain publications include explore the tissue specificity and contribution of calpain 14 in eosinophilic esophagitis.

July 21
NORD Report on Eosinophilic Esophagitis.Marc E. Rothenberg, MD, PhD, assisted in preparing this recent report about eosinophilic esophagitis by the National Organization for Rare Disorders (NORD). Learn more about his research in the Rothenberg Lab.
July 12
Allergy-Friendly On-The-Go Snacks. Carina Venter, PhD, RD, a research associate and dietician at Cincinnati Children's, and Alison Cassin, MS, RD, LD, give helpful ideas for allergy-friendly, on-the-go snacks.
July 9
. Marc E. Rothenberg, MD, PhD, and Margaret H. Collins, MD, comment about how big data and file sharing among researchers and pathologists in the Consortium of Eosinophil Gastrointestinal Disease Researchers (CEGIR) are having a major impact.
July 7
Seasonal Allergies: Is it a Cold, Flu or Allergies. Michelle B. Lierl, MD, explains how to differentiate cold, flu, and allergies in this article by Your Teen for Parents.

Angela Parker, an administrative assistant in our division, accepted the leadership position of Communications Manager with the African American Professional Advisory Committee (AAPAC) here at Cincinnati Children’s. There are currently over 300 members in the group. In this role, she is responsible for sending out information regarding community outreach, lunch and learns, tutoring opportunities and other events.

May 17

Marc Rothenberg Receives First Bunning Chair
Cincinnati Children's honored Denise and Dave Bunning for their contributions to the Division of Allergy and Immunology. Cincinnati Children's decided to use this endowment to establish a Chair in Allergy/Immunology that will bear Dave and Denise’s name. Marc E. Rothenberg, MD, PhD, will be the first incumbent of this Chair.

May 16

Scientists Identify Potential Marker of EoE Disease Activity. Patricia C. Fulkerson, MD, PhD, assistant professor in the Division of Allergy and Immunology and the Cincinnati Center for Eosinophilic Disorders at Cincinnati Children’s, led recent, preliminary research suggesting that eosinophil progenitors in the blood may be a potential marker for disease activity of eosinophilic esophagitis in children. Learn more about her research in the Fulkerson Lab.

May 13

Learning to Eat: The Importance of Texture and Food Variety. Carina Venter, PhD, RD, a research associate and dietician at Cincinnati Children's, and Kate Maslin, PhD, RD, an international collaborator, discuss the important of texture and food variety while learning to eat and its potentially life-long effect on food preferences.

April 15

Using Cloud Technology in Rare Disease Research: Interview with CEGIR Principal Investigator

April 7

NIH Study Finds Protein May Be Responsible for Damage in Eosinophilic Esophagitis

March 9

When You're Allergic to Almost Every Food

March 1

First-Place DHC Poster
Jeffrey Rymer, predoctoral fellow in the Rothenberg Lab, won the first prize for his poster at the 2016 Annual Scientific Symposium by the Digestive Health Center.

March 1

EoGenius Diagnostic Test for Eosinophilic Esophagitis
Miraca Life Sciences now offers the EoGenius test, an RNA expression test, designed to help diagnose eosinophilic esophagitis (EoE). This test is founded in research led by Marc E. Rothenberg, MD, PhD, and Ting Wen, PhD.

February 19
Research Achievement Award

Our Division Director, Marc E. Rothenberg, MD, PhD, was recognized for his dedicated efforts with a Research Achievement Award in the Fifth Annual Faculty Awards by Cincinnati Children's. To see Dr. Rothenberg receive the Research Achievement Award, view the Faculty Awards Presentation Video beginning at time point 00:39:05. Learn more about his research in the Rothenberg Lab.

February 12
NIDDK Fellowship Award

Jared Travers, an MD, PhD predoctoral fellow in the Rothenberg Lab, was awarded a fellowship grant to study the role of nuclear IL-33 in mucosal inflammation by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Learn more about his research in the Rothenberg Lab.

February 9

Improved Scoring System for the Food Allergic Disease Eosinophilic Esophagitis in Children
Researchers have developed and validated a histologic scoring system to objectively analyze pathologic features of eosinophilic esophagitis (EoE), a severe, often painful food allergy that renders children unable to eat a wide variety of foods. This study was led by researchers in the Division of Allergy and Immunology and the Cincinnati Center for Eosinophilic Disorders at Cincinnati Children’s Hospital Medical Center.

January 1

TOP DOCTOR 2016 List
In Cincinnati magazine, Michelle B. Lierl, MD, and Kimberly A. Risma, MD, PhD, were named in the TOP DOCTOR 2016 list for Allergy and Immunology subspecialty.


Research Innovation Program Award
Simon P. Hogan, PhD, was awarded funding from the Cincinnati Children's Research Innovation/Pilot Funding Program in 2016. This program will support the Hogan Lab in investigating the involvement of antibiotics in antigen sensitization in food allergy. Learn more about his research in the Hogan Lab.

Understanding Food Allergy

The National Institute of Allergy and Infectious Diseases explains food allergy and offers tips on how to manage the condition.

Ghory Lecture

The Ghory Lecture is an annual event presented by the Division of Allergy and Immunology at Cincinnati Children’s and the Cincinnati Asthma and Allergy Society. It began in 1991 and was named in honor of Joseph E. Ghory, MD.

Joseph E. Ghory, M.D.


Joseph E. Ghory, M.D. treats a patient. Dr. Joseph Ghory was born and raised in Cincinnati, Ohio. He received his M.D. from the Ohio State University College of Medicine in 1939. After completing a pediatric residency at the Children's Hospital in Cincinnati, he practiced general pediatrics in Cincinnati for 17 years.

He was devoted to teaching and was instrumental in establishing the pediatric residency training program at Good Samaritan Hospital, where he served as the first director of pediatric education. He was elected president of the Cincinnati Pediatric Society, the Children’s Hospital Medical Staff and the Academy of Medicine of Cincinnati. Impressed by the large number of children with allergic diseases, he sought additional training in allergy and became the first board-certified pediatric allergist in Cincinnati in 1960. Together with Dr. Leonard Bernstein, Dr. Ghory established the Allergy Fellowship at the University of Cincinnati and the Children’s Hospital.

Dr. Ghory’s special interest and vision was the long-term care and rehabilitation of children with intractable asthma, using a community approach with involvement of the family and a limited hospital stay. He thus became director of the Convalescent Hospital for Children in Cincinnati, organized and presided over the national Association of Convalescent Homes and Hospitals for Asthmatic Children and was chairman of the Rehabilitation Committee of the American Academy of Allergy and Immunology.

Dr. Ghory’s greatest pride was his family, and his legacy lives on in two of his daughters, Ann Ghory, M.D. and Patricia Ghory, M.D., who are practicing allergists in the Cincinnati area, and now in three of his grandchildren, who are now our young practicing and future allergists. 


2019 – William W. Busse

2018 – Seema Aceves

2017 – Elizabeth Phillips

2016 – Carina Venter

2015 – Kara Shah

2014 – Linda Cox

2013 – Kimberly Risma

2012 – David Fleischer

2011 – Amal Assa’ad


2009 – Marc Rothenberg

2008 – Scott Sicherer

2007 – Carolyn Kercsmar

2006 – Jim Gern

2005 – Sally Wenzel

2004 – Anne-Marie Irani

2003 – Donald Leung

2002 – Fernando Martinez

2001 – Marianne Frieri

2000 – Wesley Burks


1999 – Alan Kaplan

1998 – Bruce Bochner

1997 – Robert Lemanske

1996 – Peter Creticos

1995 – Michael Blais

1994 – Paul Greenberger

1993 – Elliot Ellis

1992 – Louise Marker

1991 – Sami Bahna

Allergy / Immunology Fellowship

Our recent group of fellows.
Our division offers fellowship training in pediatric and adult Allergy / Immunology in collaboration with the University of Cincinnati. Read more

Faculty Awards | Michelle Lierl, MD

Michelle B. Lierl, MD, has been recognized for her excellence in clinical care with a Clinical Care Achievement Award.

Michelle B. Lierl, MD, has been recognized for her excellence in clinical care with a Clinical Care Achievement Award.

Read More
Read the blog.
Learn more about allergy and immunology on the Cincinnati Children’s blog. Read Our Blog

Research Science Blog

Learn more about research efforts on eosinophilic conditions. The Research Horizons blog provides news and insights about the latest discoveries and innovations developed by the scientists of Cincinnati Children’s.

Read More

Research Highlights

Our research spans fundamental studies, translational investigation, and clinical trials. Novel models of immunologic diseases, developed and / or fine-tuned by divisional researchers, provide unprecedented systems to investigate key inflammatory steps involved in pediatric allergic and immunologic disease and to enhance our understanding of mast cells, eosinophils, macrophages and lymphocytes. Read More